Latest news
Allogene Therapeutics (ALLO) stake: Belldegrun group reports 3.9% ownership - Stock TitanStock Titan · Sat, 08 Aug 2026 02:12:07 GMTState Street Corporation (ALLO) discloses 5.5% beneficial stake in Allogene - Stock TitanStock Titan · Fri, 07 Aug 2026 12:33:35 GMTAnalysts Offer Insights on Healthcare Companies: Pfizer (PFE), Ultragenyx Pharmaceutical (RARE) and Allogene Therapeutics (ALLO) - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 11:18:12 GMTAllogene Therapeutics (ALLO) Expected to Release Quarterly Earnings on Wednesday - MarketBeatMarketBeat · Wed, 05 Aug 2026 13:08:26 GMTWilliam Blair Maintains Allogene Therapeutics(ALLO.US) With Buy Rating - MoomooMoomoo · Wed, 05 Aug 2026 11:31:00 GMTAllogene Therapeutics Q2 Results: Earnings Call Set for Aug 12 - scanx.tradescanx.trade · Tue, 04 Aug 2026 18:26:30 GMTAllogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 12:30:00 GMTAllogene sets Aug. 12 update on cancer and autoimmune disease - Stock TitanStock Titan · Tue, 04 Aug 2026 12:30:00 GMT